Aromatase inhibitors

N L Pill - yellow round

Pill with imprint N L is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-N L-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-N L-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-N L-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-N L-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-N L-2.5 mg-Yellow-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: N L
Strength: 2.5 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 51991-0759
Inactive Ingredients: Lactose monohydrate, Magnesium stearate, Hypromellose 2910 (6 mPa.s), Polyethylene glycol 8000, Microcrystalline cellulose, Silicon dioxide, Titanium dioxide, Ferric oxide yellow, Corn starch, Magnesium silicate, Sodium starch glycolate type A potato,
Latest News
Related Drugs